The Gross Margin of SK Biopharmaceuticals Co Ltd (326030.KS) is 92.13%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 92.13% |
| 2023-12-31 | 90.40% |
| 2022-12-31 | 84.66% |
| 2021-12-31 | 94.66% |
| 2020-12-31 | 92.41% |
| 2019-12-31 | 99.58% |
| 2018-12-31 | 100.00% |
| 2017-12-31 | 4.19% |